drugset / Trial / NCT05294263

Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans

NCT05294263

Non-randomizedParallel-groupQuadruple-blindTreatment

Summary

After initial eligibility screening, Veterans who use both cannabis and tobacco will be randomly assigned to receive either varenicline (Chantix) or placebo for 12 weeks. Participants will attend weekly visits, in person or remotely, to provide breath and urine samples for testing, fill out questionnaires, and meet with study staff about medication compliance.

Timeline

Start
2023-04-17
Primary completion
2024-07-17
Completion
2024-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Varenicline Small molecule 1 mg